Presidential Elections 2025 | Romanian Television will organize two electoral debates for the second round of the presidential elections
Sanziana Georgescu
Elections 2025
Colaj: www.shutterstock.com/ LCV: https://www.shutterstock.com/ro/catalog/licenses?q=simion & https://www.shutterstock.com/ro/catalog/licenses?q=nicusor
Always see our news on Google
<p>TVR is organizing two electoral debates on May 15 and 16, 2025, before the second round of the presidential elections. Nicușor Dan has confirmed his participation in the first debate and George Simion is expected to confirm. The broadcasts will take place in the Union Hall of the Cotroceni Palace and will be moderated by Ramona Avramescu and Marian Voicu. TVR promises a level playing field for both candidates, and public interest is growing, including from the international press.
Sources
TVR organizează două dezbateri electorale pentru turul al doilea al alegerilor prezidenţiale. Nicuşor Dan a confirmat pentru una dintre ele, iar de la George Simion se așteaptă confirmarea pentru cealaltă
Dezbatere electorală la TVR, joi seară, tot fără George Simion. Cum se va desfășura emisiunea, organizată la Palatul Cotroceni
TVR organizează două dezbateri electorale pentru turul al doilea al alegerilor prezidenţiale. Nicuşor Dan a confirmat
TVR organizează două dezbateri electorale – Nicușor Dan, joi, iar George Simion, vineri
Latest News
08:06
The U.S. Treasury debt has reached $40.047 trillion, exceeding CBO estimates. The rapid increase in the deficit raises concerns in the financial markets.
07:59
The Washington Post: Russians withdraw billions from banks, fearing that Putin will confiscate their deposits to finance his war
07:46
Hungary: The construction of a riverbed threshold on the Danube has raised the water level by 15-20 cm, preventing the shutdown of the turbines at the Paks nuclear power plant.
07:45
Kiev was the target of a new attack with Russian ballistic missiles. At least six people have died and 12 have been injured.
07:37
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
